Position in INVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,161,357
-$496,266 QoQ
Shares Held
183,239
-8.3% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. INVA ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,161,357 | 183,239 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,657,623 | 199,898 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,985,206 | 199,360 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,539,751 | 193,959 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,738,427 | 186,084 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,229,496 | 178,130 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,249,967 | 187,318 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,541,202 | 183,387 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,358,424 | 204,782 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,171,550 | 208,107 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,344,917 | 208,536 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,666,769 | 205,294 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,640,813 | 207,448 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,213,223 | 196,731 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,465,308 | 186,061 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,131,596 | 183,600 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,654,335 | 179,833 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,149,947 | 162,788 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,093,252 | 179,319 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,093,539 | 185,131 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,049,527 | 227,407 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,565,198 | 214,661 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,524,586 | 203,760 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,020,821 | 193,380 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,990,322 | 213,900 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,587,505 | 220,026 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||